Contact information
Research groups
Colleges
Rachel Horton
Rachel joined CELS in June 2018 to do a PhD. She has nearly completed her training as a clinical geneticist and is spending some time doing dedicated clinical ethics research.
Rachel’s research, funded by a Wellcome Trust Research Award for Health Professionals in Humanities and Social Sciences, explores what we should consider to be a genomic result. Genomic testing identifies the millions of variations that each of us has within our genetic code, and Rachel is interested in how and why decisions are made as to which of these variations should be considered the ‘result’ of a genomic test.
Rachel studied medicine at Oxford, doing an intercalated BA in Molecular Medicine in 2008. She worked as a junior doctor in the Severn deanery before moving to Southampton in 2015 to train in clinical genetics. She completed an MSc in Genomic Medicine at the University of Southampton in 2018.
Rachel is a Junior Research Fellow in Social Sciences at the Centre for Personalised Medicine.
Key publications
-
Direct-to-consumer genetic testing.
Journal article
Horton R. et al, (2019), BMJ (Clinical research ed.), 367
-
Consent and Autonomy in the Genomics Era.
Journal article
Horton R. and Lucassen A., (2019), Current genetic medicine reports, 7, 85 - 91
-
Genomic testing in healthcare: a hybrid space where clinical practice and research need to co-exist.
Journal article
Horton R. and Lucassen A., (2019), Expert review of molecular diagnostics, 19, 963 - 967
-
Is it acceptable to contact an anonymous egg donor to facilitate diagnostic genetic testing for the donor-conceived child?
Journal article
Horton R. et al, (2019), Journal of medical ethics, 45, 357 - 360
Recent publications
-
Genomic Data: Building Blocks for Life or Abstract Art?
Journal article
Horton R. et al, (2024), Frontiers for Young Minds, 12
-
The ethical challenges of diversifying genomic data: A qualitative evidence synthesis
Journal article
Hardcastle F. et al, (2023), Cambridge Prisms: Precision Medicine, 1 - 39
-
Ethical, Legal and Social Issues in Diversifying Genomic Data: Literature Review and Synthesis
Preprint
Hardcastle F. et al, (2022)
-
Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis.
Journal article
Horton RH. et al, (2022), British journal of cancer
-
Ethical issues raised by new genomic technologies: the case study of newborn genome screening
Journal article
Horton R. and Lucassen A., (2022), Cambridge Prisms: Precision Medicine, 1 - 16